RecruitingNot Applicable

ESP Block in MIS Lumbar Spine Surgery

United States48 participantsStarted 2023-05-15

Plain-language summary

This is a prospective, randomized controlled trial of patients undergoing minimally invasive transforaminal lumbar interbody fusion. This study will randomize patients into one of two groups: erector spinae plane (ESP) block and no ESP block.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18-80 * Patients scheduled for MIS TLIF (any level) with the principal investigator * ASA 1, 2, 3 Exclusion Criteria: * ASA 4 or higher * BMI \>40 * Chronic opioid use (daily use for \> 3 months) * Revision surgery, any history of previous lumbar spine surgery * Allergy to any of the study medications * Non-English speaking * Chronic renal insufficiency or failure (creatinine \>2) or severe hepatic disease (cirrhosis, failure) * Pregnancy * Any concomitant surgery

What they're measuring

24-hour oral morphine milligram equivalents (OMEs)

Timeframe: 24 hours postoperatively

Trial details

NCT IDNCT05856539

SponsorHospital for Special Surgery, New York

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-07-15

Contact for this trial

Sheeraz Qureshi, MD, MBA

919-260-9699 gangh@hss.edu

View on ClinicalTrials.gov More Patients With Spinal Stenosis Indicated for MIS TLIF trials